Medifast Unveils New Metabolic Health Research at ObesityWeek Conference

Reuters
11/14
Medifast Unveils New Metabolic Health Research at ObesityWeek Conference

Medifast Inc. has announced the presentation of new research findings in metabolic health at the upcoming ObesityWeek conference, hosted by The Obesity Society in Atlanta, Georgia, from November 4-7, 2025. The Medifast Scientific and Clinical Affairs (S&CA) team will present two research studies, including one co-authored by Scientific Advisory Board member Dr. Jessica Unick, which explores predictors of weight loss with a focus on adherence and early intervention. These presentations highlight Medifast's ongoing scientific initiatives and commitment to addressing metabolic dysfunction. The results are scheduled to be presented at the conference.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medifast Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251113536734) on November 13, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10